Biotech Week articles from May 2001

Biotech Week archives from May 2001

New Cyclopentane Derivative Comparable To Oseltamivir And Zanamivir.(RWJ-270201)
May 9, 2001... 2001 MAY 9 -- (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer -- An influenza virus neuraminidase inhibitor called RWJ-270201 completely protects mice against lethal infection with influenza, and compares favorably with oseltamivir...

New Tool Offers Clear Look At Cellular Proteins.(IDAT may help in cancer diagnosis)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Scientists may have identified the genes in the human genome, but proteomics is the growing field of research that describes how proteins encoded in those genes work. Researchers at the University of...

Effective Dose Range For Once-Daily Protease Inhibitor Determined.(BMS-232632)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- by Michael Greer, staff medical writer - Further study of the Bristol-Myers Squibb's once-daily anti-HIV compound BMS-232632 has determined effective concentrations of the drug designed to ease patients'...

Is Continuing Medical Education Linked Too Closely To Pharmaceutical Marketing?
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- The pharmaceutical industry is assuming a role in continuing medical education (CME) that is inappropriate for an industry with a vested interest in selling prescription drugs, according to an article in the...

Cell Fusion Inhibitors Have Synergistic Effect.(HIV therapy)
May 9, 2001... 2001 MAY 9 -- (NewsRx Network) -- by Michael Greer, staff medical writer -- Two experimental drugs that inhibit different events in the process of HIV cell entry become much more potent when used in combination, study results show. "PRO...

Flexible Stem Cells Offer Hope For Treatment.(of brain damage after stroke)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Researchers at the Institute of Psychiatry in London, England, and ReNeuron Ltd. have discovered that transplanted stem cells are capable of assisting the recovery process following a stroke by integrating into...

Implanted Mirrors Could Signal When Cancer Recurs.(analysis of reflected laser beam from implanted silicon mirror may help diagnose relapsing cancer)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Mirrors could soon reflect the health of cancer patients, according to a report in the April 14, 2001, issue of New Scientist. Instead of running regular blood tests to see if a tumor is growing back, a...

Drug Companies Drop Lawsuit Against Generics In South Africa.
May 9, 2001... 2001 MAY 9 - (NewsRx Network) --Pharmaceutical giants dropped a lawsuit on April 19, 2001, against a South African law that could provide cheaper AIDS drugs to millions of Africans, ending an international battle that deeply embarrassed the...

New Blood Purifying Device Reduces HIV Significantly In Preclinical Trials.(HIV-HemopurifierT from Aethlon Medical Inc.)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Aethlon Medical, Inc. (AEMD) is developing a promising new technology for treating HIV. The HIV-HemopurifierT is a modified dialysis cartridge that has demonstrated the ability to rapidly reduce circulating...

Funding Enables Study Of Protein/Ligand Interactions.
May 9, 2001... 2001 MAY 9 -- (NewsRx Network) -- Researchers at Aston University, U.K., have won a Biotechnology and Biological Sciences Research Council research grant worth over 300,000 British pounds to study one of the most exciting areas of science today...

Acetonitrile Has Little Effect On Murine Blood And Bone Marrow.
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- by Michael Greer, staff medical writer - The solvent acetonitrile has no significant mutagenic effects on mouse blood and bone marrow cells, according to researchers in England. E. Jones and colleagues...

Cow Hemoglobin Product Cleared For Use In South Africa.(Hemopure)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) - A product that can emulate the work of red blood cells, transporting oxygen throughout the body, has been approved for use in South Africa, the products' developers announced April 10, 2001. Hemopure, a...

Orally-Active Agent Inhibits Primary And Metastatic Tumors In Mice.(EntreMed Inc. to study Panzem)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- EntreMed, Inc. (ENMD) has released data from a preclinical study of Panzem (2-Methoxyestradiol), indicating that in addition to significantly reducing the size of primary tumors, its product Panzem very...

Proteomics Database May Help Identify New Anti-HIV Compounds.(Hybrigenics launches protein database)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Hybrigenics, Paris, France, announced the launch of what it calls "the world's most comprehensive combined protein-protein interactions 'map' between the human immunodeficiency virus (HIV) and its host cell in...

Liposomal Agent Successfully Carries Therapeutic Genes To Tumors.(Introgen Therapeutics Inc.'s Fragile Hystidine Triad Protein and p53 are successful in carrying gene therapeutics)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Introgen Therapeutics, Inc. (INGN) announced April 17, 2001, the publication of a preclinical study in the April 2001 issue of Molecular Therapy indicating that a liposomal vector can successfully deliver...

Goal Of DITTO-HCV Study Is Treatment Tailored To Each Patient's Therapeutic Response.(Ceplene to be tested in the new Dynamically Individualized Treatment of Hepatitis C Infection and Correlates of Viral/Host Dynamics method)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Maxim Pharmaceuticals (MAXM) has announced that its product Ceplene [TM] (histamine dihydrochloride) will be tested in a new multi-national clinical study, the "Dynamically Individualized Treatment of Hepatitis...

Phase I Clinical Trial Of Plasmid DNA-Based Vaccine Is Enrolling Patients.(HIV vaccine testing)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- A Phase I, placebo-controlled study to examine the safety, tolerability, and immunogenicity of an experimental HIV vaccine consisting of plasmid DNA. The manufacturer of the experimental vaccine is Merck &...

NewsRx.net Is Preferred Site for Cancer, Malaria, AIDS, Other Health Searches, Audience Measurement Shows.
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- NewsRx Network, Atlanta, Georgia, the leading provider of life science databases and daily and weekly health news, announced on April 17, 2001, the results of audience measurements based on its report from...

NucliSens Test Offers High Accuracy For Gonorrhea, Chlamydia Detection.(Oganon Teknika offers NucliSens Basic Kit)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - A new RNA amplification and detection assay offers high sensitivity and specificity for detection of Neisseria gonorrhoeae and Chlamydia trachomatis, according to a...

Assay Helps Determine Immunity To Hepatitis B Virus.(Ortho-Clinical Diagnostics Inc. offers Vitros Immunodiagnostic Products Anti-HBs Reagent Pack and Calibrators)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- The first diagnostic anti-hepatitis B surface antigen assay on a random access system has received Premarket Approval (PMA) by the U.S. Food and Drug Administration's Center for Devices and Radiological Health....

Adjuvants Improve Potency Of Epidermal Powder Immunization.(against influenza)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - Epidermal powder immunization (EPI) is an attractive delivery route for vaccination and has shown some success in mice immunized against influenza. Now researchers...

Designer Molecules Link Together To Make Nanotubes A Snap.
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Inspired by nature's own building blocks, Purdue University researchers are using the same principle that makes DNA strands link together to create tiny structures that may someday be used to manufacture...

Once-Daily Dosing Holds Concentrations But With Side Effects.(Fortovase dosage for HIV treatment)
May 9, 2001... 2001 MAY 9 -- (NewsRx Network) -- Roche announced April 18, 2001, preliminary clinical data from four ongoing studies examining tolerability and antiviral activity with once-daily dosing of its protease inhibitor [Fortovase.sup.R] (saquinavir)...

Nitric Oxide Not Involved In Interferon-Induced Hepatitis C Replicon Clearance.
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- Researchers with Roche Discovery, U.K., have determined that nitric oxide does not have a role in interferon-gamma (IFN-gamma) induced hepatitis C replicon clearance. They also report that mechanisms of...

Researchers Explain Adenoviral Purification Techniques.(for human gene therapy use)
May 9, 2001... 2001 MAY 9 - (NewsRx Network) -- by Deborah W. Heinrich, staff medical writer - Scientists at Transgene SA in Strasbourg, France, described the rigorous methods used to screen recombinant adenovirus vectors for human use in gene therapy. ...

Modified Chemokine Improves Stem Cell Mobilization.
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- by Michael Greer, senior medical writer - Researchers in Pennsylvania have shown that an altered human chemokine acts as a potent stem cell mobilizer, several times more powerful than drugs currently used to...

Reported Distributions Of S. pneumoniae Serotypes May Be Inaccurate.(Streptococcus )
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - Differences diagnostic and reporting practices in America and Europe, rather than a difference in geographic epidemiology, may account for the variance in serotypes of...

Use Of Bovine Immunodeficiency Virus Reduces Risk.
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- by Deborah W. Heinrich, PhD, staff medical writer - Researchers at Chemocentryx in San Carlos, California, infected non-dividing human cells with bovine immunodeficiency virus to study the safety of this...

Intranasal Vaccine Delivery Stimulates Potent Immune Response.
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - A new intranasal influenza vaccine performs better than several other delivery systems and stimulates strong immune responses in pigs, report Chiron Corporation...

Gene Therapy Inhibits Blood Vessel Growth In Eyes.
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- GenVec, Inc. (GNVC) announced May 2, 2001, data demonstrating that administration in the eye of the pigment epithelium-derived factor (PEDF) gene using GenVec's proprietary gene delivery technology resulted in...

CDR2 BV6S2/6S5 Peptide Vaccine Safe And Immunogenic.(multiple sclerosis )
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - Eight of 10 patients with multiple sclerosis (MS) developed peptide-specific immune responses after being immunized with a T-cell receptor (TCR) V[beta] vaccine,...

Tissue-Engineered Product Introduced At Symposium.(Composite Cultured Skin )(wound healing )
May 16, 2001... 2001 MAY 16 - (NewsRx.Network) -- Ortec International, Inc. (ORTC), announced that its lead product, Composite Cultured Skin (CCS), was introduced to the wound healing community at The 14th Annual Symposium on Advanced Wound Care and Medical...

Drug Companies Start Phase II Monotherapy Clinical Trials.(Abgenix, Inc.and Immunex Corp., ABX-EGF as monotherapy for kidney cancer)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Abgenix, Inc. (ABGX) and Immunex Corp. (IMNX) announced April 18, 2001, that the companies will start a Phase II clinical trial of ABX-EGF in patients with kidney cancer. The Phase II trial will assess the...

Five Vaccine Formulations Safe, Immunogenic In Humans.(dengue)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - Five live, attenuated dengue vaccines are safe and well-tolerated in humans, report virologists with the U.S. army. N. Kanesa-Thasan and colleagues at the Walter...

Data Indicate Vagus Nerve Stimulation Effective For Depressed.
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Cyberonics, Inc. (CYBX) announced May 2, 2001, that results of a preliminary study show vagas nerve stimulation (VNS) therapy may effectively normalize sleep abnormalities in depressed patients Results of...

Intellectual Property And Patent Protection Are New Concerns.
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- The most critical challenges facing pharmaceutical, biotechnology, and medical product companies over the next two to three years are intellectual property and patent protection, enterprise technology,...

Patent Awarded For Gene Associated With High Cholesterol.(to Gemini Genomics, PLC)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Gemini Genomics, PLC (GMNI) announced April 16, 2001, that it has been issued a patent (U.S. Patent No. 6,218,524) for a gene that can identify a predisposition to the type of high cholesterol that leads to the...

Hormones Improve Immune Response to HBV Vaccination in Aged Animals.(hepatitis B vaccine )
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Preclinical results with a Hollis-Eden Pharmaceuticals, Inc. (HEPH) investigational drug candidate, HE2200, an immune-regulating hormone, demonstrated that HE2200 and other immune-regulating hormones given to...

Two-Stage Approach Achieves 20-Fold Uptake Of Chemotherapeutic.(Pentacea)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Immunomedics, Inc. (IMMU) presented results May 2, 2001, on a new method for improved targeting of drugs and isotopes to cancers. Dr. David M. Goldenberg, Immunomedics, described progress being made in...

Catalytic Activity Of Anti-Inflammatory Compounds Increased 100-Fold.(drugs that mimic the action of superoxide dismutase)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Researchers at MetaPhore Pharmaceuticals have used computer-aided design techniques to achieve a 100-fold increase in the catalytic activity of one of the company's synthetic manganese-based compounds...

Clinical Trials Start For Ventricular Assist Device.(MicroMed DeBakey Ventricular Assist Device)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- MicroMed Technology, Inc., announced April 18, 2001, that it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin its pivotal multi-center clinical study of the MicroMed...

Data Indicate Vertreporfin Is Able To Stabilize Vision.(Visudyne )
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Data presented May 1, 2001, at a symposium held during the annual Association for Research in Vision and Ophthalmology (ARVO) conference showed that average visual acuity remained stable during the third year...

Enzyme-Replacement Drug Is Granted Orphan Drug Status For Mucopolysaccharidosis.(iduronidase)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Novazyme Pharmaceuticals, Inc., announced April 17, 2001, that the company was granted orphan drug status for its proprietary treatment for mucopolysaccharidosis I (MPS I). This notification from the U.S....

NCI Funds HIV Fusion.(National Cancer Institute funds research at Panacos Pharmaceuticals, Inc. to develop drugs that prevent HIV from fusing to cell membranes)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Panacos Pharmaceuticals, Inc., announced April 11, 2001, that it has signed a Cooperative Research and Development Agreement (CRADA) with the U.S. National Cancer Institute (NCI) to discover drug candidates...

Vaccine Elicits High Responses In Non-Responders.(hepatitis B vaccine)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- PowderJect Pharmaceuticals, Plc (PJP) announced April 24, 2001, the first achievement of protective immunity by a DNA vaccine in volunteers who do not respond to current commercial hepatitis B vaccines. ...

Cardiac And Pregnancy Assays Are Being Tested For Emergency Room Use.(FasTraQ system)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Quantech Ltd. (QQQQ) announced May 2, 2001, that Minneapolis Medical Research Foundation (MMRF) has begun clinical studies of the Quantech FasTraQ[TM] instrument system and PrePaQ[TM] cardiac and pregnancy test...

Phase III Clinical Data Support Use Of Oral Chemotherapy.(treatment of metastatic colorectal cancer)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- The April 15, 2001, edition of the Journal of Clinical Oncology features Phase III clinical data about the use of Roche's [Xeloda.sup.R] (capaceitabine), an oral chemotherapy, in the first-line treatment of...

FDA Issues Addiction Drug Warning.(levomethadyl acetate HC, brand name Orlaam, can cause arrhythmia)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- The U.S. Food and Drug Administration (FDA) has issued a stronger warning about a drug used to treat opiate addiction. The agency said on April 20, 2001, that the new warning is the result of 10 cases of...

New Class of Synthetic Antibodies Is Described.(Semorex Inc.)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- A new class of molecularly imprinted polymers (MIPs) has the ability to bind to small molecules and to target molecules such as organics and proteins with equal or greater potency than that of natural...

Grant Awarded To Develop Diagnostic Device.(Sequella, Inc., tuberculosis)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Sequella, Inc., announced on April 23, 2001, that it received a Small Business Innovative Research (SBIR) Grant from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) that will drive...

FDA Approves Pacemaker The Size Of Two Quarters.(St. Jude Medical Microny II SR+ AutoCapture Pacing System)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- St. Jude Medical, Inc. (STJ) announced May 2, 2001, it has received pre-market approval from the U.S. Food and Drug Administration (FDA) to release the St. Jude Medical [Microny.sup.R] II SR+ AutoCapture[TM]...

Immunotherapy Agent Found Effective In 73% Of Patients.(HspE7, treatment for anal dysplasia)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Stressgen Biotechnologies Corp. (TSE:SSB) announced April 24, 2001, preliminary Phase II data confirming previously reported activity of HspE7, a novel immunotherapeutic, for the treatment of a precancerous...

Oxycyte Study In Rats Completed.(perfluorocarbon-based blood substitute)
May 16, 2001... 2001 MAY 16 - (NewsRx Network) -- Synthetic Blood International Inc. (SYBD) announced on May 4, 2001, the successful completion of a blood replacement study with Oxycyte[TM] in rats. "The positive outcome in this type of study model will...

Cell Genesys Reports Antitumor Activity In Phase I/II GVAX Vaccine Trial.
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Cell Genesys, Inc. (CEGE) reported interim clinical data from its multicenter Phase I/II [GVAX.sup.R] lung cancer vaccine trial that demonstrate objective evidence of antitumor activity including a major...

Galantamine Therapy Shows Sustained Cognitive Benefits.(Reminyl for Alzheimer's disease treatment)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Cognitive benefits of galantamine treatment are likely to be sustained for at least two years in patients with Alzheimer's disease, according to a study presented at the American Academy of Neurology's 53rd...

Ghrelin Levels Low in Obese Humans.(growth hormone ligand)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - The growth hormone ligand ghrelin may be critical in the pathogenesis of human obesity, according to a study published in Diabetes. Ghrelin levels were lower in...

Tumor Suppressor Gene Also Regulates Gene For Autosomal Dominant PKD.(polycystic kidney disease)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Researchers at the CIIT Centers for Health Research and the University of Texas M.D. Anderson Cancer Center have discovered that a tumor suppressor gene that inhibits kidney cancer also controls a major gene...

Higher Chickenpox Vaccination Rates Decrease Disease Even In The Unvaccinated.
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- With more than 60% of children being vaccinated, the "vaccine has been administered to a high enough proportion of the children in the population that incidence of varicella disease has decreased within the...

Study Finds Not All Blood Tests Are Created Equal.(blood test results for allergy diagnosis vary)
May 23, 2001... 201 MAY 23 - (NewsRx Network) -- The results of most commonly used blood tests for allergies can vary widely depending on which laboratory does the actual testing - and which laboratory procedure is used, a new study suggests. This means...

Therapeutic Vaccine Prolongs Survival Time For Patients With Metastatic Disease.(vaccinia-CEA(V) and ALVAC-CEA(A) increase survival time)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Demonstrating new success in cancer immunotherapy, researchers reported that they have increased the survival time of cancer patients using novel therapeutic vaccines. Data show, for the first time, that...

Antibody Therapy Kills Cancer Cells In Culture.(HMFG1 uses body's immune system to kill cancer)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- In a study published in the May 2001 online version of the International Journal of Cancer, scientists from the Free University Medical Center, Amsterdam, showed that humanized HMFG1, a novel cancer-targeting...

Technology May Quicken Pace Of Protein Research.(Random Activation of Gene Expression can accelerate research in functional genomics)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Scientists with a company called Athersys have reported on a technology they say can dramatically accelerate the pace of research in the field of functional genomics. The May 2001 issue of Nature...

Canarypox-CMV pp65 Vaccine Stimulates Long-Lasting Immune Response.(cytomegalovirus)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - A vaccine consisting of the major matrix phosphoprotein 65 (pp65) of cytomegalovirus (CMV) plus canarypox is able to stimulate pp65-specific antibody responses that are...

Cell Cycle Affects Nuclear Import Of Plasmid DNA.
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- by Deborah W. Heinrich, PhD, staff medical writer - Current research has vastly improved the efficiency of cationic lipid-mediated gene transfer. The next step will be to improve transgene expression in target...

FDA Approves Moxifloxacin HCL For Treatment Of Bacterial Skin Infections.
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- The U.S. Food and Drug Administration (FDA) has approved the use of [Avelox.sup.R] (moxifloxacin HCl), the second fluoroquinolone antibiotic from Bayer Corp., as a once-daily treatment for uncomplicated skin...

BACTEC Assay Useful For Gauging Individual Drug Resistance.(in Mycobacterium tuberculosis)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - A whole-blood bactericidal assay offers the chance to evaluate the likely effectiveness of anti-microbials against Mycobacterium tuberculosis strains in individual...

Cytokine and Kinase Inhibitors Effective Against Inflammation.(SelCIDs Selective Cytokine Inhibitory Drugs)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Celgene Corp. (CELG) scientists and collaborators have presented data that show Celgene's SelCIDs [TM] (Selective Cytokine Inhibitory Drugs) and novel JNK (c-Jun N-terminal Kinase) inhibitor have significant...

Human Decay-Accelerating Factor Protects Baculovirus From Complement.
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- by Deborah W. Heinrich, PhD, staff medical writer -- Vectors derived from recombinant baculovirus have been shown to preferentially transfect hepatocytes. Therefore, their use in gene therapy for liver cancers...

Amiosterol Compound Controls Appetite In Animal Models.
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Genaera Corp. (GENR) reports that the company's second aminosterol development compound, produlestan, has shown potent and specific appetite suppressant properties in animal models. According to a report...

Peptide Vaccine Induces Immune Response In 80% Of Trial Patients.(T-Cell Receptor peptide vaccine for the treatment of multiple sclerosis)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- The Immune Response Corp. (IMNR) has published data on its investigational T-Cell Receptor (TCR) peptide vaccine for multiple sclerosis (MS) showing that it induced a specific response (stimulation index...

Anti-Thrombin Protein Enters Preclinical Testing.(MPC-1203 protein drug tested for efficiency in treatment of acute thrombotic events)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Myriad Genetics, Inc. (MYGN) reports that it has begun preclinical testing of its proprietary protein drug MPC-1203 for the treatment of acute thrombotic events such as those due to inflammation following major...

NewsRx Network Chosen As Source For 'Information Therapy'.
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- NewsRx Network, Atlanta, Georgia, the leading provider of life science databases and daily and weekly health news, now is a major source for "information therapy." NewsRx databases are derived from medical...

New Data Suggest Novartis Drug Effective In Rare Form of Gastrointestinal Tumor.(Gleevec effective in treatment of stromal tumor and soft tissue sarcoma)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- Novartis Oncology's signal transduction inhibitor, Gleevec[TM] (imatinib mesylate; formerly STI571), was highlighted during the key plenary session of the 37th annual meeting of the American Society of Clinical...

FDA Advisors Say Three Prescription Drugs Are Safe Enough To Be Over-The Counter.(allergy medications Claritin, Allegra, and Zytec are safe enough to be marketed without doctor approval)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- A advisory panel to the U.S. Food and Drug Administration (FDA) has decided that three popular allergy drugs are safe enough to sell without prescription, but experts say the path to over-the-counter sales may...

Timing And Duration Influence LIPUS Fracture Repair.(low-intensity pulsed ultrasound)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- by Sonia Nichols, senior medical writer -- A new report suggests several physiological factors, including angiogenesis and chondrogenesis, are affected during treatments with low-intensity pulsed ultrasound...

'Smart' Drug Fails Independent Clinical Testing.(piracetam for Down syndrome)
May 23, 2001... 2001 MAY 23 - (NewsRx Network) -- One of the first studies of a so-called "smart drug" for Down syndrome suggests it does not boost children's intellectual ability, despite testimonials on television and the Internet. In fact, the drug,...